EUCTR2006-005842-35-ITActive, not recruitingNot Applicable
Efficacy and safety of treatment with N-butyl-deoxynojirimycin (NB-DNJ-miglustat) in patients with Niemann-Pick disease type C. - ND
Dipartimento di Pediatria Universita` di Napoli Federico II0 sitesStarted: October 28, 2009Last updated:
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Diagnosis of NPC confirmed by biochemical tests (filipin staining and LDL-cholesterol esterification) and/or molecular analysis
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •Patients unable to take the drug Bad compliance to study procedures Patients with renal failure Fertile women that do not consent to oral contraceptives during the study and until three months after discontinuation of treatment
Investigators
Similar Trials
Completed
Not Applicable
Clinical Research on the Efficacy of Bosinji on Low Back Pain and Radiculopathy by Herniated Intervertebral Disc of Lumbar SpineDiseases of the musculo-skeletal system and connective tissueKCT0002848Kyung Hee University74
Completed
Phase 4
Effectiveness and safety of bromocriptine when it is combined with metformin in Indian patients with type II diabetes mellitusCTRI/2012/05/002659Dr Nilanjan Sengupta60
Completed
Phase 1
Botulinum toxin-loaded detachable dissolvable microneedles for primary axillary hyperhidrosis: A pilot study on efficacy and safetyaxillary sweatingMicroneedle Transdermal Botulinum Toxin Botox Patch testTCTR20201230002Material and Bio interface10
Not yet recruiting
Not Applicable
Treatment of primary palmar hyperhidrosisSkin and Connective Tissue DiseasesPACTR202006915898923Mansoura university faculty of medicine80
Not yet recruiting
Phase 4
Evaluating the efficacy and safety of (Embella®) in management of superficial lipomassuperficial lipoma.Benign lipomatous neoplasmIRCT20240416061507N2Espad pharmed10